None listed
Conditions
Interventions
Procedure/Surgery : We used 4 ml of 0.5%
bupivacaine 20mg/4ml/A (20mg) (AstraZeneca, Seoul, Korea), 15 ml of normal saline, 0.5 ml of 0.8%
indigo-carmine dye 40mg/5ml/A (4mg) (Korea United pharm, Seoul, Korea), and 0.5 ml of 0.1%
epinephrine 1mg/ml/A (0.5mg) (Danhan pharm, Seoul, Korea) for the BP group in this study. On the other hand, we used conventional solution consisting of 19 ml of normal saline, 0.5 ml of 0.8%
indigo-carmine dye, and 0.5 ml of 0.1%
epinephrine for the placebo group.
Sponsors
Hallym University Medical Center-Dongtan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: We prospectively evaluated consecutive patients with ages of 20 or older who were scheduled to undergo ESD for pathologically diagnosed or clinically suspected gastric adenoma or cancer at Hallym medical center.
Exclusion criteria
Exclusion criteria: (1) declining to provide informed consent; (2) American Society of Anesthesiology risk Class 3 or higher; (3) severe hepatic disease or cardiopulmonary or renal dysfunction; (4) current analgesics including non-steroidal anti-inflammatory drug use during the preceding week; (5) allergy to bupivacaine or other amide-type local anesthesia; (6) confirmation of any other disease that could induce abdominal pain similar with post-ESD pain; (7) presence of multiple lesions requiring endoscopic resection in one patient; (8) current pregnancy or breast feeding; (9) impossible to assess pain such as severe psychiatric or neurologic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the visual analogue scale | — |
Secondary
| Measure | Time frame |
|---|---|
| the visual analogue scale;short-form McGill pain (SF-MP) score;short-form McGill pain (SF-MP) score;procedure related adverse events | — |
Countries
Korea, Republic of
Contacts
Public ContactSe Woo Park
Hallym University Medical Center-Dongtan
Outcome results
None listed